Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer
about
Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectivesA phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancerHigh curative resection rate with weekly cisplatin, 5-fluorouracil, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim in patients with locally advanced, unresectable gastric cancer: a report from the Italian Group for the Study of DigestiveIntensive weekly chemotherapy for locally advanced gastric cancer using 5-fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer (GISCAD).Effectiveness of immunochemotherapy for gastric cancer: a review of the current status.Alterations in p53 predict response to preoperative high dose chemotherapy in patients with gastric cancerPreoperative (neoadjuvant) chemoradiotherapy in oesophageal cancer.Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trialsGastric carcinoma.Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancerMulticenter randomized phase II study of cisplatin and fluorouracil plus docetaxel (DCF) compared with cisplatin and fluorouracil plus Adriamycin (ACF) as preoperative chemotherapy for resectable esophageal squamous cell carcinoma (OGSG1003).Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial.Pathological complete remission in patients with oesophagogastric cancer receiving preoperative 5-fluorouracil, oxaliplatin and docetaxel.
P2860
Q26774283-9BDE339F-D5D4-40BE-A679-34C5566BF36BQ28350903-FB6874B3-EA1D-491C-B9D4-7A8D0496A1ABQ33360403-F2E7FD06-81CF-46A7-ADA0-2328DE76CE11Q33503301-1D85B07F-6A18-4C83-9532-F54C1E8E3760Q33712779-D144A19F-A4C4-4980-AE80-25C5F0641969Q33919232-C1CCCBF9-65CD-40E1-AD97-78ECD1B85357Q34190498-BE42196F-8CF4-4D40-983F-39D8E97A2BE7Q35002601-802D2012-72DE-46CD-8170-9123334ED4CEQ35739065-63944561-9890-4BD5-A5FE-9DFD0F695C5EQ36402491-B8A0B939-FBB2-466B-A180-7A1CF7094AC1Q40559737-4241BD14-7EB1-4F56-AA8E-0EA0EDA41412Q42285544-302BEF1F-7E6F-4116-9EE4-8E39293AEC88Q44143001-ACD14C4D-2A71-4488-A302-7361F76B9D79
P2860
Epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) as neoadjuvant chemotherapy in gastro-oesophageal cancer
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Epirubicin, cisplatin and cont ...... y in gastro-oesophageal cancer
@ast
Epirubicin, cisplatin and cont ...... y in gastro-oesophageal cancer
@en
type
label
Epirubicin, cisplatin and cont ...... y in gastro-oesophageal cancer
@ast
Epirubicin, cisplatin and cont ...... y in gastro-oesophageal cancer
@en
prefLabel
Epirubicin, cisplatin and cont ...... y in gastro-oesophageal cancer
@ast
Epirubicin, cisplatin and cont ...... y in gastro-oesophageal cancer
@en
P2093
P2860
P356
P1476
Epirubicin, cisplatin and cont ...... y in gastro-oesophageal cancer
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1996.604
P407
P577
1996-11-01T00:00:00Z